Circulating IL-17A Levels in Postmenopausal Women with Primary Hyperparathyroidism
Background. Primary hyperparathyroidism (PHPT) is a common cause of secondary osteoporosis in postmenopausal women. Th17 lymphocytes and the released cytokine IL-17A play an important role in bone metabolism. Th17 cells have been shown to be activated by PTH, and peripheral blood T cells from patien...
Main Authors: | E. Dozio, E. Passeri, E. Vianello, S. Palmieri, C. Eller-Vainicher, M. Corsi Romanelli, S. Corbetta |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2020/3417329 |
Similar Items
-
Symptomatic Hypercalcemia in Patients with Primary Hyperparathyroidism Is Associated with Severity of Disease, Polypharmacy, and Comorbidity
by: C. Aresta, et al.
Published: (2019-01-01) -
Update on denosumab in the management of postmenopausal osteoporosis: patient preference and adherence
by: Cairoli E, et al.
Published: (2015-10-01) -
Circulating Irisin Is Reduced in Male Patients with Type 1 and Type 2 Myotonic Dystrophies
by: Elena Dozio, et al.
Published: (2017-11-01) -
Incidence of Secondary Hyperparathyroidism among Postmenopausal Women with End-Stage Knee Osteoarthritis
by: Kyriakos A Papavasiliou, et al.
Published: (2009-12-01) -
Serum IL-17 and postmenopausal osteoporosis
by: Tharwa H. AL-Tai
Published: (2016-01-01)